PURPOSE: We compared the use of near-infrared conjugates of 2-deoxyglucose (NIR 2-DG) to 2-deoxy-2-[18F]fluoro-d-glucose (18F-FDG) for the purposes of imaging tumors, as well as response to therapy. PROCEDURES: Uptake of both 18F-FDG and NIR 2-DG within gastrointestinal stromal tumor xenografts were imaged before and after nilotinib treatment. Confocal microscopy was performed to determine NIR 2-DG distribution in tumors. RESULTS: Treatment with nilotinib resulted in a rapid reduction in 18F-FDG uptake and reduced tumor cell viability which was predictive of long-term antitumor efficacy. In contrast, optical imaging with NIR 2-DG probes was unable to differentiate control from niltonib-treated animals, and microscopic analysis revealed no change in probe distribution as a result of treatment. CONCLUSIONS: These results suggest that conjugation of large bulky fluorophores to 2-DG disrupts the facilitated transport and retention of these probes in cells. Therefore, optical imaging of NIR 2-DG probes cannot substitute for 18F-FDG positron emission tomography imaging as a biomarker of tumor cell viability and metabolism.
PURPOSE: We compared the use of near-infrared conjugates of 2-deoxyglucose (NIR 2-DG) to 2-deoxy-2-[18F]fluoro-d-glucose (18F-FDG) for the purposes of imaging tumors, as well as response to therapy. PROCEDURES: Uptake of both 18F-FDG and NIR 2-DG within gastrointestinal stromal tumor xenografts were imaged before and after nilotinib treatment. Confocal microscopy was performed to determine NIR 2-DG distribution in tumors. RESULTS: Treatment with nilotinib resulted in a rapid reduction in 18F-FDG uptake and reduced tumor cell viability which was predictive of long-term antitumor efficacy. In contrast, optical imaging with NIR 2-DG probes was unable to differentiate control from niltonib-treated animals, and microscopic analysis revealed no change in probe distribution as a result of treatment. CONCLUSIONS: These results suggest that conjugation of large bulky fluorophores to 2-DG disrupts the facilitated transport and retention of these probes in cells. Therefore, optical imaging of NIR 2-DG probes cannot substitute for 18F-FDG positron emission tomography imaging as a biomarker of tumor cell viability and metabolism.
Authors: Amy B Blodgett; Rajendra K Kothinti; Ivan Kamyshko; David H Petering; Suresh Kumar; Niloofar M Tabatabai Journal: Diabetes Technol Ther Date: 2011-04-21 Impact factor: 6.118
Authors: Dirk B Mendel; A Douglas Laird; Xiaohua Xin; Sharianne G Louie; James G Christensen; Guangmin Li; Randall E Schreck; Tinya J Abrams; Theresa J Ngai; Leslie B Lee; Lesley J Murray; Jeremy Carver; Emily Chan; Katherine G Moss; Joshua O Haznedar; Juthamas Sukbuntherng; Robert A Blake; Li Sun; Cho Tang; Todd Miller; Sheri Shirazian; Gerald McMahon; Julie M Cherrington Journal: Clin Cancer Res Date: 2003-01 Impact factor: 12.531
Authors: Clay H Holdsworth; Ramsey D Badawi; Judith B Manola; Marie F Kijewski; David A Israel; George D Demetri; Annick D Van den Abbeele Journal: AJR Am J Roentgenol Date: 2007-12 Impact factor: 3.959
Authors: Joy L Kovar; William Volcheck; Eva Sevick-Muraca; Melanie A Simpson; D Michael Olive Journal: Anal Biochem Date: 2008-10-07 Impact factor: 3.365
Authors: John O Prior; Michael Montemurro; Maria-Victoria Orcurto; Olivier Michielin; François Luthi; Jean Benhattar; Louis Guillou; Valérie Elsig; Roger Stupp; Angelika Bischof Delaloye; Serge Leyvraz Journal: J Clin Oncol Date: 2008-12-08 Impact factor: 44.544
Authors: Ellen Weisberg; Paul W Manley; Werner Breitenstein; Josef Brüggen; Sandra W Cowan-Jacob; Arghya Ray; Brian Huntly; Doriano Fabbro; Gabriele Fendrich; Elizabeth Hall-Meyers; Andrew L Kung; Jürgen Mestan; George Q Daley; Linda Callahan; Laurie Catley; Cara Cavazza; Mohammad Azam; Azam Mohammed; Donna Neuberg; Renee D Wright; D Gary Gilliland; James D Griffin Journal: Cancer Cell Date: 2005-02 Impact factor: 31.743
Authors: John C McAuliffe; Kelly K Hunt; Alexander J F Lazar; Haesun Choi; Wei Qiao; Peter Thall; Raphael E Pollock; Robert S Benjamin; Jonathan C Trent Journal: Ann Surg Oncol Date: 2008-10-25 Impact factor: 5.344
Authors: Silvan Türkcan; Julia Nguyen; Marta Vilalta; Bin Shen; Frederick T Chin; Guillem Pratx; Paul Abbyad Journal: Anal Chem Date: 2015-06-15 Impact factor: 6.986
Authors: Marcello Panagia; Howard H Chen; Dominique Croteau; Yin-Ching Iris Chen; Chongzhao Ran; Ivan Luptak; Lee Josephson; Wilson S Colucci; David E Sosnovik Journal: Circ Cardiovasc Imaging Date: 2018-03 Impact factor: 7.792
Authors: Jun Wang; Kiwook Hwang; Daniel Braas; Alex Dooraghi; David Nathanson; Dean O Campbell; Yuchao Gu; Troy Sandberg; Paul Mischel; Caius Radu; Arion F Chatziioannou; Michael E Phelps; Heather Christofk; James R Heath Journal: J Nucl Med Date: 2013-08-26 Impact factor: 10.057
Authors: Guillem Pratx; Kai Chen; Conroy Sun; Lynn Martin; Colin M Carpenter; Peter D Olcott; Lei Xing Journal: PLoS One Date: 2012-10-03 Impact factor: 3.240
Authors: Narasimhan Rajaram; Amy E Frees; Andrew N Fontanella; Jim Zhong; Katherine Hansen; Mark W Dewhirst; Nirmala Ramanujam Journal: PLoS One Date: 2013-10-18 Impact factor: 3.240
Authors: Erica C Nakajima; Charles Laymon; Matthew Oborski; Weizhou Hou; Lin Wang; Jennifer R Grandis; Robert L Ferris; James M Mountz; Bennett Van Houten Journal: PLoS One Date: 2014-08-15 Impact factor: 3.240